Cellectar Biosciences, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cellectar Biosciences, Inc. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $34.87K, a 99.81% decline year-over-year.
- Cellectar Biosciences, Inc. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $18.26M, a 102.32% increase year-over-year.
- Cellectar Biosciences, Inc. stock issued during period, value, new issues for the quarter ending 2019-06-30 was $9.02M.
- Cellectar Biosciences, Inc. stock issued during period, value, new issues for the quarter ending 2018-09-30 was $15.03M.
- Cellectar Biosciences, Inc. stock issued during period, value, new issues for fiscal 2025 was $5.79M.
- Cellectar Biosciences, Inc. stock issued during period, value, new issues for fiscal 2023 was $17.92M.
- Cellectar Biosciences, Inc. stock issued during period, value, new issues for fiscal 2021 was $34.87K, a 99.94% decline from fiscal 2020.
- Cellectar Biosciences, Inc. stock issued during period, value, new issues for fiscal 2020 was $59.72M, a 561.74% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $5.79M 10-K · filed 2026-03-04 | |
| 2023-12-31 | $17.92M 10-K · filed 2024-03-27 | |
| 2021-12-31 | $34.87K 10-K · filed 2023-03-09 | |
| 2021-06-30 | $34.87K 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $59.72M 10-K · filed 2021-03-02 | |
| 2020-06-30 | $18.26M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $9.02M 10-K · filed 2021-03-02 | |
| 2019-06-30 | $9.02M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $15.03M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $15.03M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $7.05M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $15.50M 10-K · filed 2018-03-21 | |
| 2015-12-31 | $2.87M 10-K · filed 2017-03-15 | |
| 2014-12-31 | $11.88M 10-K/A · filed 2016-10-20 | |
| 2013-12-31 | $4.98M 10-K · filed 2015-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |